From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Definition
Mean
SD
Base utility while no relapse
0.77
0.12
Tariff at relapse
−0.18
0.03
Tariff after 6 months
−0.10
0.02
Tariff after 12 months
−0.07
0.01
Tariff after 18 months